Ruppert-Kohlmayr A J, Uggowitzer M M, Kugler C, Zebedin D, Schaffler G, Ruppert G S
Department of Radiology, University Hospital of Graz, Auenbruggerplatz 9, A-8036 Graz, Austria.
AJR Am J Roentgenol. 2001 Jun;176(6):1493-8. doi: 10.2214/ajr.176.6.1761493.
Differences of attenuation and enhancement patterns in focal nodular hyperplasia and hepatocellular adenoma were evaluated and quantified using triphasic single-slice helical CT.
Forty-five histologically proven focal nodular hyperplasias in 27 patients and 18 hepatocellular adenomas in six patients were examined with helical CT. Quantitative evaluation included the following: attenuation of lesions, scar, and liver parenchyma during unenhanced, arterial (20 sec after injection), and portal venous phases (70 sec after injection); relative enhancement of lesions and liver (the ratio between attenuation in arterial phase and portal venous phase, respectively, and attenuation in unenhanced phase); and the prevalence of scar and its central vessel in focal nodular hyperplasia.
The study showed no significant difference between mean attenuation values of focal nodular hyperplasia (mean +/- SD, 51.2 +/- 5.9 H) and hepatocellular adenoma (mean +/- SD, 56.3 +/- 7.8 H) in the unenhanced phase. In the arterial phase attenuation values were significantly higher in focal nodular hyperplasia (mean +/- SD, 117.9 +/- 15.1 H) than in hepatocellular adenoma (mean +/- SD, 80.1 +/- 10.5 H). In the portal venous phase no significant differences in attenuation values were detected between focal nodular hyperplasia (mean +/- SD, 112.1 +/- 20.4 H) and hepatocellular adenoma (mean +/- SD, 110.2 +/- 12.9 H). For enhancement parameter thresholds separating focal nodular hyperplasia from hepatocellular adenoma, the following were found: the relative enhancement was higher in 100% of the focal nodular hyperplasias and lower than or equal to 1.6 (accuracy, 96%) in 87% of the hepatocellular adenomas.
Triphasic helical CT combined with quantitative evaluation of liver lesions offers the possibility of detecting differences in liver lesions that are visually similar on CT. The attenuation and relative enhancement in the arterial phase show significant differences that make accurate differentiation between focal nodular hyperplasia and hepatocellular adenoma possible.
采用螺旋CT三期扫描,对肝局灶性结节性增生(FNH)和肝细胞腺瘤(HCA)的衰减及强化模式差异进行评估和量化。
对27例患者的45个经组织学证实的FNH和6例患者的18个HCA进行螺旋CT检查。定量评估包括:平扫、动脉期(注射后20秒)和门静脉期(注射后70秒)病变、瘢痕及肝实质的衰减;病变和肝脏的相对强化(动脉期和门静脉期衰减值分别与平扫期衰减值之比);以及FNH中瘢痕及其中心血管的发生率。
研究显示,平扫期FNH(均值±标准差,51.2±5.9H)和HCA(均值±标准差,56.3±7.8H)的平均衰减值无显著差异。动脉期,FNH的衰减值(均值±标准差,117.9±15.1H)显著高于HCA(均值±标准差,80.1±10.5H)。门静脉期,FNH(均值±标准差,112.1±20.4H)和HCA(均值±标准差,110.2±12.9H)的衰减值无显著差异。对于区分FNH和HCA的强化参数阈值,结果如下:100%的FNH相对强化较高,87%的HCA相对强化低于或等于1.6(准确率96%)。
螺旋CT三期扫描结合肝脏病变的定量评估,能够发现CT图像上视觉相似的肝脏病变之间的差异。动脉期的衰减和相对强化显示出显著差异,使得FNH和HCA的准确鉴别成为可能。